The pathobiology of Krüppel-like factors in colorectal cancer

Current Colorectal Cancer Reports

Volumn 4, Issue 2, 2008, Pages 59-64

  Ghaleb, Amr M ^b   Yang, Vincent W ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 62049086099     PISSN: 15563790     EISSN: 15563804     Source Type: Journal    
DOI: 10.1007/s11888-008-0011-4     Document Type: Review

References (68)

1. American Cancer Society: Cancer Facts & Figures 2007. Atlanta: American Cancer Society; 2007. Available at http://www.cancer.org/downloads/STT/ CAFF2007PWSecured. pdf. Accessed December 7, 2007.
2. Hisamuddin IM, Yang VW: Molecular genetics of colorectal cancer: An overview. Curr Colorectal Cancer Rep 2006, 2:53-59.
3. Muto T, Bussey HJ, Morson BC: The evolution of cancer of the colon and rectum. Cancer 1975, 36:2251-2270.
4. Fearon ER, Vogelstein B: A genetic model for colorectal tumorigenesis. Cell 1990, 61:759-767.
5. Wood LD, Parsons DW, Jones S, et al.: The genomic landscapes of human breast and colorectal cancers. Science 2007, 318:1108-1113.
6. Vogelstein B, Kinzler KW: Cancer genes and the pathways they control. Nat Med 2004, 10:789-799.
7. Schuh R, Aicher W, Gaul U, et al.: A conserved family of nuclear proteins containing structural elements of the fnger protein encoded by Krüppel, a Drosophila segmentation gene. Cell 1986, 47:1025-1032.
8. Bieker JJ: Krüppel-like factors: three fngers in many pies. J Biol Chem 2001, 276:34355-34358.
9. Black AR, Black JD, Azizkhan-Clifford J: Sp1 and Krüppel-like factor family of transcription factors in cell growth regulation and cancer. J Cell Physiol 2001, 188:143-160.
10. Dang DT, Pevsner J, Yang VW: The biology of the mammalian Krüppel-like family of transcription factors. Int J Biochem Cell Biol 2000, 32:1103-1121.
11. Kaczynski J, Cook T, Urrutia R: Sp1-and Krüppel-like transcription factors. Genome Biol 2003, 4:206.
12. Ghaleb AM, Nandan MO, Chanchevalap S, et al.: Krüppel-like factors 4 and 5: the yin and yang regulators of cellular proliferation. Cell Res 2005, 15:92-96.
13. McConnell BB, Ghaleb AM, Nandan MO, Yang VW: The diverse functions of Krüppel-like factors 4 and 5 in epithelial biology and pathobiology. Bioessays 2007, 29:549-557.
14. Narla G, Friedman SL, Martignetti JA: Krüppel cripples prostate cancer: KLF6 progress and prospects. Am J Pathol 2003, 162:1047-1052.
15. Wang X, Zhao J: KLF8 transcription factor participates in oncogenic transformation. Oncogene 2007, 26:456-461.
16. Ellenrieder V, Buck A, Harth A, et al.: KLF11 mediates a critical mechanism in TGF-beta signaling that is inactivated by Erk-MAPK in pancreatic cancer cells. Gastroenterology 2004, 127:607-620.
17. Shields JM, Christy RJ, Yang VW: Identifcation and characterization of a gene encoding a gut-enriched Krüppel-like factor expressed during growth arrest. J Biol Chem 1996, 271:20009-20017.
18. Shields JM, Yang VW: Two potent nuclear localization signals in the gut-enriched Krüppel-like factor defne a subfamily of closely related Krüppel proteins. J Biol Chem 1997, 272:1850 4-18507.
19. Shields JM, Yang VW: Identifcation of the DNA sequence that interacts with the gut-enriched Krüppel-like factor. Nucleic Acids Res 1998, 26:796-802.
20. Zhang W, Shields JM, Sogawa K, et al.: The gut-enriched Krüppel-like factor suppresses the activity of the CYP1A1 promoter in an Sp1-dependent fashion. J Biol Chem 1998, 273:17917-17925.
21. Ton-That H, Kaestner KH, Shields JM, et al.: Expression of the gut-enriched Krüppel-like factor gene during development and intestinal tumorigenesis. FEBS Lett 1997, 419:239-243.
22. Chen X, Johns DC, Geiman DE, et al.: Krüppel-like factor 4 (gut-enriched Krüppel-like factor) inhibits cell proliferation by blocking G1/S progression of the cell cycle. J Biol Chem 2001, 276:30423-30428.
23. Yoon HS, Chen X, Yang VW: Krüppel-like factor 4 mediates p53-dependent G1/S cell cycle arrest in response to DNA damage. J Biol Chem 2003, 278:2101-2105.
24. Yoon HS, Yang VW: Requirement of Krüppel-like factor 4 in preventing entry into mitosis following DNA damage. J Biol Chem 2004, 279:5035-5041.
25. Zhang W, Geiman DE, Shields JM, et al.: The gut-enriched Krüppel-like factor (Krüppel-like factor 4) mediates the transactivating effect of p53 on the p21WAF1/CIP1 promoter. J Biol Chem 2000, 275:18391-18398.
26. Chen X, Whitney EM, Gao SY, Yang VW: Transcriptional profling of Krüppel-like factor 4 reveals a function in cell cycle regulation and epithelial differentiation. J Mol Biol 2003, 326:665-677.
27. Dang DT, Bachman KE, Mahatan CS, et al.: Decreased expression of the gut-enriched Krüppel-like factor gene in intestinal adenomas of multiple intestinal neoplasia mice and in colonic adenomas of familial adenomatous polyposis patients. FEBS Lett 2000, 476:203-207.
28. Dang DT, Chen X, Feng J, et al.: Overexpression of Krüppel-like factor 4 in the human colon cancer cell line RKO leads to reduced tumorigenecity. Oncogene 2003, 22:3424-3430.
29. Dang DT, Mahatan CS, Dang LH, et al.: Expression of the gut-enriched Krüppel-like factor (Krüppel-like factor 4) gene in the human colon cancer cell line RKO is dependent on CDX2. Oncogene 2001, 20:4884-4890.
30. Clevers H: Wnt/beta-catenin signaling in development and disease. Cell 2006, 127:469-480.
31. Stone CD, Chen ZY, Tseng CC: Gut-enriched Krüppel-like factor regulates colonic cell growth through APC/beta-catenin pathway. FEBS Lett 2002, 530:147-152.
32. Zhang W, Chen X, Kato Y, et al.: Novel cross talk of Krüppel-like factor 4 and beta-catenin regulates normal intestinal homeostasis and tumor repression. Mol Cell Biol 2006, 26:2055-2064.
33. Ghaleb AM, McConnell BB, Nandan MO, et al.: Haploinsuffciency of Krüppel-like factor 4 promotes adenomatous polyposis coli dependent intestinal tumorigenesis. Cancer Res 2007, 67:7147-7154.
34. Moser AR, Pitot HC, Dove WF: A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science 1990, 247:322-324.
35. Shie JL, Chen ZY, O'Brien MJ, et al.: Role of gut-enriched Krüppel-like factor in colonic cell growth and differentiation. Am J Physiol Gastrointest Liver Physiol 2000, 279:G806-G814.
36. Zhao W, Hisamuddin IM, Nandan MO, et al.: Identifcation of Krüppel-like factor 4 as a potential tumor suppressor gene in colorectal cancer. Oncogene 2004, 23:395-402.
37. Yoon HS, Ghaleb AM, Nandan MO, et al.: Krüppel-like factor 4 prevents centrosome amplifcation following gamma-irradiation-induced DNA damage. Oncogene 2005, 24:4017-4025.
38. Katz JP, Perreault N, Goldstein BG, et al.: The zinc-fnger transcription factor Klf4 is required for terminal differentiation of goblet cells in the colon. Development 2002, 129:2619-2628.
39. van Es JH, van Gijn ME, Riccio O, et al.: Notch/gamma-secretase inhibition turns proliferative cells in intestinal crypts and adenomas into goblet cells. Nature 2005, 435:959-963.
40. de Lau W, Barker N, Clevers H: WNT signaling in the normal intestine and colorectal cancer. Front Biosci 2007, 12:471-491.
41. Conkright MD, Wani MA, Anderson KP, Lingrel JB: A gene encoding an intestinal-enriched member of the Krüppel-like factor family expressed in intestinal epithelial cells. Nucleic Acids Res 1999, 27:1263-1270.
42. Sogawa K, Imataka H, Yamasaki Y, et al.: cDNA cloning and transcriptional properties of a novel GC box-binding protein, BTEB2. Nucleic Acids Res 1993, 21:1527-1532.
43. Ohnishi S, Laub F, Matsumoto N, et al.: Developmental expression of the mouse gene coding for the Krüppel-like transcription factor KLF5. Dev Dyn 2000, 217:421-429.
44. Shindo T, Manabe I, Fukushima Y, et al.: Krüppel-like zinc-fnger transcription factor KLF5/BTEB2 is a target for angiotensin II signaling and an essential regulator of cardiovascular remodeling. Nat Med 2002, 8:856-863.
45. Sun R, Chen X, Yang VW: Intestinal-enriched Krüppel-like factor (Krüppel-like factor 5) is a positive regulator of cellular proliferation. J Biol Chem 2001, 276:6897-6900.
46. Chanchevalap S, Nandan MO, Merlin D, Yang VW: All-trans retinoic acid inhibits proliferation of intestinal epithelial cells by inhibiting expression of the gene encoding Krüppel-like factor 5. FEBS Lett 2004, 578:99-105.
47. Zhang H, Bialkowska A, Rusovici R, et al.: Lysophos-phatidic acid facilitates proliferation of colon cancer cells via induction of Krüppel-like factor 5. J Biol Chem 2007, 282:15541-15549.
48. Ziemer LT, Pennica D, Levine AJ: Identifcation of a mouse homolog of the human BTEB2 transcription factor as a ß-catenin-independent Wnt-1-responsive gene. Mol Cell Biol 2001, 21:562-574.
49. Chen C, Bhalala HV, Qiao H, Dong JT: A possible tumor suppressor role of the KLF5 transcription factor in human breast cancer. Oncogene 2002, 21:6567-6572.
50. Chen C, Bhalala HV, Vessella RL, Dong JT KLF5 is frequently deleted and down-regulated but rarely mutated in prostate cancer. Prostate 2003, 55:81-88.
51. Nandan MO, Chanchevalap S, Dalton WB, Yang VW: Krüppel-like factor 5 promotes mitosis by activating the cyclin B1/Cdc2 complex during oncogenic Ras-mediated transformation. FEBS Lett 2005, 579:4757-4762.
52. Nandan MO, Yoon HS, Zhao W, et al.: Krüppel-like factor 5 mediates the transforming activity of oncogenic H-Ras. Oncogene 2004, 23:3404-3413.
53. Du JX, Yun CC, Bialkowska A, Yang VW: Protein inhibitor of activated STAT1 interacts with and up-regulates activities of the pro-proliferative transcription factor Krüppel-like factor 5. J Biol Chem 2007, 282:4782-4793.
54. Bateman NW, Tan D, Pestell RG, et al.: Intestinal tumor progression is associated with altered function of KLF5. J Biol Chem 2004, 279:12093-12101.
55. Nandan MO, McConnell BB, Ghaleb AM, et al.: Krüppel-like factor 5 mediates cellular transformation during oncogenic KRAS-induced intestinal tumorigenesis. Gastroenterology 2008, 134:120-130.
56. Bos JL, Fearon ER, Hamilton SR, et al.: Prevalence of ras gene mutations in human colorectal cancers. Nature 1987, 327:293-297.
57. Koritschoner NP, Bocco JL, Panzetta-Dutari GM, et al.: A novel human zinc fnger protein that interacts with the core promoter element of a TATA box-less gene. J Biol Chem 1997, 272:9573-9580.
58. Okano J, Opitz OG, Nakagawa H, et al.: The Krüppel-like transcriptional factors Zf9 and GKLF coactivate the human keratin 4 promoter and physically interact. FEBS Lett 2000, 473:95-100.
59. Narla G, Heath KE, Reeves HL, et al.: KLF6, a candidate tumor suppressor gene mutated in prostate cancer. Science 2001, 294:2563-2566.
60. Benzeno S, Narla G, Allina J, et al.: Cyclin-dependent kinase inhibition by the KLF6 tumor suppressor protein through interaction with cyclin D1. Cancer Res 2004, 64:3885-3891.
61. Kremer-Tal S, Reeves HL, Narla G, et al.: Frequent inactivation of the tumor suppressor Krüppel-like factor 6 (KLF6) in hepatocellular carcinoma. Hepatology 2004, 40:1047-1052.
62. Cho YG, Kim CJ, Park CH, et al.: Genetic alterations of the KLF6 gene in gastric cancer. Oncogene 2005, 24:4588-4590.
63. Reeves HL, Narla G, Ogunbiyi O, et al.: Krüppel-like factor 6 (KLF6) is a tumor-suppressor gene frequently inactivated in colorectal cancer. Gastroenterology 2004, 126:1090-1103.
64. Cho YG, Choi BJ, Kim CJ, et al.: Genetic alterations of the KLF6 gene in colorectal cancers. APMIS 2006, 114: 458-464.
65. Cho YG, Choi BJ, Song JW, et al.: Aberrant expression of Krüppel-like factor 6 protein in colorectal cancers. World J Gastroenterol 2006, 12:2250-2253.
66. Mukai S, Hiyama T, Tanaka S, et al.: Involvement of Krüppel-like factor 6 (KLF6) mutation in the development of nonpolypoid colorectal carcinoma. World J Gastroen-terol 2007, 13:3932-3938.
67. Miyaki M, Yamaguchi T, Iijima T, et al.: Difference in the role of loss of heterozygosity at 10p15 (KLF6 locus) in colorectal carcinogenesis between sporadic and familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer patients. Oncology 2006, 71:131-135.
68. Lievre A, Landi B, Cote JF, et al.: Absence of mutation in the putative tumor-suppressor gene KLF6 in colorectal cancers. Oncogene 2005, 24:7253-7256.